(Q53771166)

19 May 2018

title

Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. (English)

1 reference

19 May 2018

1 reference

A L Eddleston

1

1 reference

19 May 2018

R Williams

series ordinal

2

1 reference

19 May 2018

language of work or name

English

0 references

publication date

1 December 1974

1 reference

19 May 2018

published in

The Lancet

1 reference

19 May 2018

volume

2

1 reference

19 May 2018

issue

7896

1 reference

19 May 2018

page(s)

1543-1545

1 reference

19 May 2018

Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Association of autoimmune active chronic hepatitis with HL-A1,8.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Immunoglobulin Deposition in Liver of Patients with Active Chronic Hepatitis and Antibody against Smooth Muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Cell-mediated Immune Responses in Chronic Liver Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Cellular immunity and hepatitis-associated, Australia antigen liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Infusion of hepatitis-B antibody in antigen-positive active chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Incidence and Meaning of Persistence of Australia Antigen in Patients with Acute Viral Hepatitis: Development of Chronic Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

HL-A, immune-response genes, and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Raised antibody titres to measles and rubella viruses in chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Increased incidence of HL-A 1 and 8 in patients showing IgG or complement coating on their red cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

Letter: Transfer-factor therapy of chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2990287-6

7 January 2021

10.1016/S0140-6736(74)90287-6

Identifiers

DOI

1 reference

19 May 2018

1 reference

19 May 2018